Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents.

Documenti analoghi

• Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome.
  di: Yajko, D M, et al.
  Pubblicazione: (1987)
• Effects of antimicrobial agents on survival of Mycobacterium avium complex inside alveolar macrophages obtained from patients with human immunodeficiency virus infection.
  di: Yajko, D M, et al.
  Pubblicazione: (1991)
• Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.
  di: Yajko, D M, et al.
  Pubblicazione: (1988)
• In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
  di: Yajko, D M, et al.
  Pubblicazione: (1990)
• Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.
  di: Majumdar, S, et al.
  Pubblicazione: (1992)